Document is current
Any future updates will be listed below
-
Authors
Murphy, Caitlin E. http://orcid.org/0000-0003-0216-6912
Lawther, Adam J.
Webster, Maree J.
Asai, Makoto
Kondo, Yuji
Matsumoto, Mitsuyuki
Walker, Adam K.
Weickert, Cynthia Shannon
-
Funding
Funding for this research was provided by:
National Breast Cancer Foundation Australia (PF-15-014)
NSW Ministry of Health
National Health and Medical Research Council (1117079)
National Institute of Alcohol Abuse and Alcoholism of the National Institutes of Health (R28AA012725)
Department of Education, Skills and Employment (Research Training Program)
Neuroscience Research Australia
- License Information
-
More Information
Article History
Received: 28 April 2020
Accepted: 6 July 2020
First Online: 17 July 2020
Ethics approval and consent to participate
: The present study was performed in accordance with the latest version of the Declaration of Helsinki after review by the Human Research Ethics Committee at the University of New South Wales (UNSW; HREC #12435) and the latest version of the SMRI ethics (ExternalRef removed). Human tissues were received from the New South Wales Brain Tissue Resource Centre (TRC) at the University of Sydney (which is supported by the University of Sydney and The Schizophrenia Research Institute) and the Stanley Medical Research Institute (SMRI). TRC specimens were collected as part of the “Using our Brains” donor program established in 2002 as a pre-mortem consent program. SMRI specimens were collected with informed consent from next-of-kin between September 1993 and June 2005. All animal experimental procedures were approved by the Institutional Animal Care and Use Committee of Astellas Pharma Inc. (Ibaraki, Japan), which has been awarded Accreditation Status by the Association of Assessment and Accreditation of Laboratory Animal Care (AAALAC) International.
: Not applicable.
: CSW is on an advisory board for Lundbeck, Australia Pty. The other authors declare that they have no competing interests.
